{
  "docId": "019de071-805e-75da-a9c3-e9573cb6e94f",
  "docSlug": "f179c2894ff7ef65a3c6d24dd4bec442",
  "documentTitle": "Exscientia | IPO Presentation Deck | 60 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7893755,
  "pageNumber": 27,
  "pageCount": 60,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a three-column structure to define the target product profile (TPP) for a drug candidate.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-805e-75da-a9c3-e9573cb6e94f/27",
  "deckHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f",
  "deckJsonHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f.json",
  "deckAnchorHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.28,
        "x": 0.05,
        "y": 0.725
      },
      "kind": "callout",
      "text": "Design needs to achieve potency and selectivity non-covalently",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00bee3da-8f42-42a0-8f89-d68d1027d0e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.28,
        "x": 0.36,
        "y": 0.725
      },
      "kind": "callout",
      "text": "Product needs to be highly potent, but with a short half-life",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6304cf5e-2ad6-4a88-872d-bf2481f38875",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.28,
        "x": 0.67,
        "y": 0.725
      },
      "kind": "callout",
      "text": "Goal is for very rapid absorption at the lowest possible dose",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96591127-a865-44b3-8a66-b3a41721f0c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.67,
        "y": 0.25
      },
      "kind": "list",
      "text": "Bioavailable: CDK7 inhibition will lead to toxicity if it remains at any site other than the tumour. Absorption variability will cause either supra-doses or sub-therapeutic dosing.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c407f24-dbcf-4bb0-b262-f2e6e4c0c934",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "Non-covalent potency and selectivity: Both potency and selectivity are critically important. Early entrants increased potency and selectivity by covalent bonding. This dramatically increased off target toxicity, leading to discontinuation.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c54446ce-3472-41bf-8434-5829b562abef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.36,
        "y": 0.25
      },
      "kind": "list",
      "text": "Short therapeutic window: Ideal therapeutic coverage would be 6-8 hours at IC80. Longer periods will lead to increasing systemic toxicity.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6f6453b-3950-4ee4-952d-83d01a2dbc92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.72,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "title",
      "text": "Mechanism requires a tightly controlled target product profile",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0097473-f997-46ca-a405-25649df64bf6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "CDK7: Precision design to maximise effectiveness",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9ceb658-ea25-480b-968f-5f0dbb7b1956",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "Target Product Profile",
      "slug": null,
      "matchId": "3c3f456e-24ee-426d-8f73-0304e3cd6135",
      "evidence": "The slide explicitly defines the requirements for a drug candidate's profile.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 60,
      "from": 4,
      "beatId": "5dda98c6-c560-4b21-aa1c-95b617a27a20",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The deck presents a comprehensive solution throughout pages 4-60.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 60,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "3b6b60bf-18b7-4458-bffa-eba1b1ca0583",
      "evidence": "The deck presents a comprehensive loop on the golden circle of problem-solution-benefit.",
      "position": 1,
      "objective": "Explain how Exscientia's AI-driven platform can solve the problem of inefficient drug discovery.",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}